Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02757859 · ClinicalTrials.gov registry record · NA
High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery
A NA study of Pancreatic Ductal Adenocarcinoma and Pancreatic Adenocarcinoma, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.
- Recruiting
- Registry status
- NA
- Development phase
- 845
- Enrollment target
- 2
- Study locations
NCT02757859: Recruiting NA study of Pancreatic Ductal Adenocarcinoma and Pancreatic Adenocarcinoma, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.
NCT02757859 is a NA study of Pancreatic Ductal Adenocarcinoma and Pancreatic Adenocarcinoma that is actively recruiting participants, run by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University. The registered enrollment target is 845 participants, above the 591-participant average among 84 other Pancreatic Ductal Adenocarcinoma trials with a reported enrollment target (43% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02757859, a NA study of Pancreatic Ductal Adenocarcinoma and Pancreatic Adenocarcinoma, is actively recruiting participants, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.
- RECRUITING
- Registry status
- NA
- Development phase
- 845 participants
- Enrollment target
- 2
- Study locations
Study Summary
This randomized clinical trial studies how well high volume washing of the abdomen works in increasing survival after surgery in patients with pancreatic cancer that can be removed by surgery. High volume washings may remove free floating cancers present after surgery and help prolong survival in patients with pancreatic cancer.
Primary Outcome
Will use a one-sided log-rank test to separately compare lavage (EAL-S or EAL-W) to no lavage with respect to OS. Assuming the study is not stopped at the interim analyses, the final comparison will be made with an alpha level of 0.02493. Distribution of OS will be estimated using the Kaplan-Meier method. Secondary analyses will use Cox regression to adjust the lavage/no lavage comparison for other baseline patient and/or characteristics known to be associated with OS.
Conditions Studied
Interventions
- PROCEDURE Pancreatectomy
- OTHER Lavage
Study Locations (2)
Ohio
- Case Western Reserve University - Cleveland
Pennsylvania
- Sidney Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 845 participants |
| Start Date | 2016-04-27 |
| Est. Completion | 2026-04-27 |
| Phase | NA |
What NCT02757859 shows while recruiting
NCT02757859 is an interventional study that assigns participants to a tested intervention. The registered 845 participants enrollment target is mid-sized for trials with a published cap, above the 591-participant average among 84 other Pancreatic Ductal Adenocarcinoma trials with a reported enrollment target (43% higher).
The record links to 8 conditions, with Pancreatic Ductal Adenocarcinoma appearing as the primary indexed condition, and to 2 interventions - of which Pancreatectomy is the first listed.
NCT02757859 reports a single indexed study location in Ohio, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02757859 about?
NCT02757859 is a clinical study titled "High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery". This randomized clinical trial studies how well high volume washing of the abdomen works in increasing survival after surgery in patients with pancreatic cancer that can be removed by surgery. High volume washings may remove free floating cancers present after surgery and help prolong survival in pa...
What is the current status of trial NCT02757859?
This trial is currently recruiting. It is a NA study. The enrollment target is 845 participants. The study started on 2016-04-27. Estimated completion is 2026-04-27.
What conditions does trial NCT02757859 study?
This clinical trial studies the following conditions: Pancreatic Ductal Adenocarcinoma, Pancreatic Adenocarcinoma, Cholangiocarcinoma, Acinar Cell Carcinoma, Pancreatic Intraductal Papillary Mucinous Neoplasm.
What interventions are being tested in trial NCT02757859?
The interventions under investigation include: Pancreatectomy (PROCEDURE), Lavage (OTHER).
Who is sponsoring clinical trial NCT02757859?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, which has 138 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02757859 being conducted?
This trial has 2 study locations across Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Ductal Adenocarcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02757859's enrollment target sits among peer trials
845 8th of 84 higher than 77 of 84 other Pancreatic Ductal Adenocarcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pancreatic Ductal Adenocarcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer
RECRUITING · NA
-
Physical Activity and Nutrition to Halt Elevated Risk in the Pancreas Interception Center
ACTIVE NOT RECRUITING · NA
-
Maintenance Combinatorial Myeloid Immunotherapy for Unresectable Pancreatic Cancer
RECRUITING · Phase 2
-
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
RECRUITING · Phase 1
-
A Registry to Capture Patient Outcomes With KRAS G12R Altered Advanced Pancreatic Ductal Adenocarcinoma Treated With MEK Inhibitor-based Combination Therapy
RECRUITING
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06747949 · 844 participants · Phase 3
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
- NCT06439979 · 843 participants · NA
Rural Adult and Youth Sun Protection Study
- NCT07142408 · 848 participants · Phase 3
The Effect of Bacterial Decolonization Before Skin Cancer Surgery on Infection Rate of Lower Extremity Wounds Left Open to Heal
- NCT06027788 · 842 participants · NA
CTSN Embolic Protection Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI